BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guan S, He Y, Su Y, Zhou L. A Risk Signature Consisting of Eight m(6)A Methylation Regulators Predicts the Prognosis of Glioma. Cell Mol Neurobiol 2022;42:2733-43. [PMID: 34432221 DOI: 10.1007/s10571-021-01135-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen P, Xu J, Cui Z, Wu S, Xie T, Zhang X. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1071675] [Reference Citation Analysis]
2 Wu S, Ballah AK, Che W, Wang X. M7G-related LncRNAs: A comprehensive analysis of the prognosis and immunity in glioma. Front Genet 2022;13. [DOI: 10.3389/fgene.2022.961278] [Reference Citation Analysis]
3 Wang Z, Zhong Z, Jiang Z, Chen Z, Chen Y, Xu Y. A novel prognostic 7-methylguanosine signature reflects immune microenvironment and alternative splicing in glioma based on multi-omics analysis. Front Cell Dev Biol 2022;10:902394. [DOI: 10.3389/fcell.2022.902394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]